Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Prebiotics
United Therapeutics Europe Ltd
Prebiotics
1 trial -
Pregabalin
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
1 trial -
Pregabalin capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Fibromyalgia
1 trial -
Preoperative Genotyping
BRIGHT MINDS BIOSCIENCES INC.
PPAP
1 trial -
Prepackaged Low-Residue Diet
Universal Integrated
Bowel Preparation Solution
1 trial -
Probiotic
United Therapeutics Europe Ltd
Stress Physiology
1 trial -
Probiotics
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Probiotics
Sun Yat-sen University
Cardiometabolic Risk Factors
1 trial -
Probiotics daily
Xiyuan Hospital of China Academy of Chinese Medical Sciences
SARS-CoV-2
1 trial -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Cessation
1 trial -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Abuse
2 trials -
Progesterone
BRIGHT MINDS BIOSCIENCES INC.
Tobacco Use Cessation
1 trial -
Propranolol + Bleomycin
Universal Integrated
Infantile Hemangioma (IH)
1 trial -
Prospan cough Syrup
Hong Kong Baptist University
Cough Severity
1 trial -
Prostate biopsy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Prostate biopsy guided by PSMA PET/CT
The First People's Hospital of Lianyungang
PSMA PET/CT
1 trial -
Protocol-based management of perioperative antithrombotic therapy
Peking University Third Hospital
Antithrombotic Therapy
1 trial -
Protocol-based management of perioperative antithrombotic therapy
The First People's Hospital of Lianyungang
Antithrombotic Therapy
1 trial -
Prunes
United Therapeutics Europe Ltd
Perimenopausal Bone Loss
1 trial -
Pueraria lobata radix
The First People's Hospital of Lianyungang
Type 2 Diabetes Mellitus
1 trial -
Pyridoxal-5'-Phosphate supplement
AVENUE THERAPEUTICS, INC.
Neural Inhibition
1 trial -
QiMeiYan Probiotics
Chongqing Precision Biotech Co., Ltd
IBS - Irritable Bowel Syndrome
1 trial -
Qingre Huashi Granules combined the modified dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
R-CDOP
The First People's Hospital of Lianyungang
Diffuse Large B Cell Lymphoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources